AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2015
Jan 26, 2015
31523_dirs_2015-01-26_5844f9bf-fc50-452a-9b02-c1ffc84b7f65.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-01-23
Reporting Person: Do Hung (Sr Vice President Discovery)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-23 | Common stock | D | 41441 | $8.097 | Disposed | 870281 | Direct |
Footnotes
F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2014.
F2: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.87 to $8.31. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.